OpenAI Introduces GPT-Rosalind-6 to Help Scientists Study Diseases and Develop Medicines
OpenAI has introduced GPT-Rosalind-6, an advanced artificial intelligence model designed for biological research, drug discovery, and medicine development. The model is intended to help qualified scientists work through complicated research problems involving biological information, experimental results, and potential medical treatments. According to a technical report published on October 30, 2026, GPT-Rosalind-6 will only be available…